A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure

International Journal of Cardiology

Volumn 137, Issue 1, 2009, Pages 1-8

  Alper, A Brent ^a   Campbell, Ruth C ^b   Anker, Stefan D ^d   Bakris, George ^e   Wahle, Christy ^b   Love, Thomas E ^c   Hamm, L Lee ^a   Mujib, Marjan ^b   Ahmed, Ali ^b,f  

^a TULANE UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF CHICAGO   (United States)

^f BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Elderly; Heart failure; Hospitalization; Mortality; Potassium; Propensity score

Indexed keywords

DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; NITRIC ACID DERIVATIVE; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; CARDIAC PATIENT; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RACE DIFFERENCE; SCORING SYSTEM; SEX DIFFERENCE;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; POTASSIUM;

EID: 69049093170     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.05.047     Document Type: Article

References (32)

1. Ahmed A., Husain A., Love T.E., et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27 (2006) 1431-1439
2. Ahmed A., Zannad F., Love T.E., et al. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 28 (2007) 1334-1343
3. Ahmed A., Young J.B., Love T.E., Levesque R., and Pitt B. A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure. Int J Cardiol (2007)
4. Ahmed A. Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. J Gerontol A Biol Sci Med Sci 62 (2007) 323-329
5. Ahmed A., and Aronow W.S. A propensity-matched study of the association of physical function and outcomes in geriatric heart failure. Arch Gerontol Geriatr 46 2 (2008) 161-172
6. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
7. Macdonald J.E., and Struthers A.D. What is the optimal serum potassium level in cardiovascular patients?. J Am Coll Cardiol 43 (2004) 155-161
8. Ahmed A., Pitt B., Rahimtoola S.H., et al. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial. Int J Cardiol 123 (2008) 138-146
9. Sui X., Gheorghiade M., Zannad F., Young J.B., and Ahmed A. A propensity matched study of the association of education and outcomes in chronic heart failure. Int J Cardiol 129 (2008) 93-99
10. Weitzen S., Lapane K.L., Toledano A.Y., Hume A.L., and Mor V. Principles for modeling propensity scores in medical research: a systematic literature review. Pharmacoepidemiol Drug Saf 13 (2004) 841-853
11. Ahmed A., Perry G.J., Fleg J.L., Love T.E., Goff Jr. D.C., and Kitzman D.W. Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis. Am Heart J 152 (2006) 956-966
12. Normand S.T., Landrum M.B., Guadagnoli E., et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54 (2001) 387-398
13. Rubin D.B. On principles for modeling propensity scores in medical research. Pharmacoepidemiol Drug Saf 13 (2004) 855-857
14. SPSS. SPSS 15 for Windows. rel 14 ed Chicago IL 2007.
15. Coca S.G., Perazella M.A., and Buller G.K. The cardiovascular implications of hypokalemia. Am J Kidney Dis 45 (2005) 233-247
16. Schulman M., and Narins R.G. Hypokalemia and cardiovascular disease. Am J Cardiol 65 (1990) 4E-9E [discussion 22E-23E]
17. Ascherio A., Rimm E.B., Hernan M.A., et al. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation 98 (1998) 1198-1204
18. Lin H., and Young D.B. Interaction between plasma potassium and epinephrine in coronary thrombosis in dogs. Circulation 89 (1994) 331-338
19. McCabe R.D., Bakarich M.A., Srivastava K., and Young D.B. Potassium inhibits free radical formation. Hypertension 24 (1994) 77-82
20. McCabe R.D., and Young D.B. Potassium inhibits cultured vascular smooth muscle cell proliferation. Am J Hypertens 7 (1994) 346-350
21. Srivastava T.N., and Young D.B. Impairment of cardiac function by moderate potassium depletion. J Card Fail 1 (1995) 195-200
22. Brilla C.G., Rupp H., Funck R., and Maisch B. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur Heart J 16 Suppl O (1995) 107-109
23. Ramires F.J., Mansur A., Coelho O., et al. Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 85 (2000) 1207-1211
24. Zannad F., Dousset B., and Alla F. Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship. Hypertension 38 (2001) 1227-1232
25. Brown M.J., Brown D.C., and Murphy M.B. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med 309 (1983) 1414-1419
26. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
27. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 (1999) 709-717
28. Petch M.C., McKay R., and Bethune D.W. The effect of beta, adrenergic blockade on serum potassium and glucose levels during open heart surgery. Eur Heart J 2 (1981) 123-126
29. Rosa R.M., Silva P., Young J.B., et al. Adrenergic modulation of extrarenal potassium disposal. N Engl J Med 302 (1980) 431-434
30. Frost L., Bottcher M., Botker H.E., Kristensen S.D., and Norgaard A. Enalapril and exercise-induced hyperkalemia. A study of patients randomized to double-blind treatment with enalapril or placebo after acute myocardial infarction. Int J Cardiol 37 (1992) 401-405
31. Gennari F.J. Hypokalemia. N Engl J Med 339 (1998) 451-458
32. Ahmed A., Adamopoulos C., Sui X., and Love T.E. Potassium supplement use may increase hospitalization without affecting mortality in chronic heart failure: implications for use of aldosterone antagonists to maintain potassium balance in chronic heart failure. Circulation 116 (2007) II-766